G protein-coupled receptors (GPCRs) respond to diversified extracellular stimuli to modulate cellular function. Traditionally, activated receptors couple to G proteins, which transduce downstream signals via second messengers and membrane channels. 1 Active GPCRs are phosphorylated by specific GPCR kinases (GRKs) leading to receptor desensitization. Arrestin proteins then bind to the phosphorylated receptor initializing clathrin-mediated internalization. 2 Despite extensive studies investigating the regulation of single GPCR signaling cascades, the effect of concomitant GPCR activation by endogenous stimuli on downstream signaling remains poorly understood. There is a great deal of evidence supporting functional crosstalk between different GPCRs both in vitro and in vivo. [3] [4] [5] The majority of these studies focus on short-term stress responses involved in modulation of common effectors such as G proteins, phospholipases (PLs), and adenylyl cyclases. 4 However, chronic activation of multiple GPCR signaling pathways during maladaptive tissue and organ remodeling suggests the potential of downstream crosstalk away from the plasma membrane.
One potential nexus for GPCR signaling crosstalk are the multifunctional scaffold proteins known as arrestins. Arrestins not only scaffold proteins for the activation of different MAPK families under single receptor activation, but also mediate transactivation of epidermal growth factor receptor signaling pathways 2, 6 and activation of many other non-GPCR signaling cascades. 7 In the case of GPCR-induced extracellular signalregulated kinase (ERK) mitogen-activated protein kinase (MAPK) activation, both G proteins and arrestins are capable of mediating ERK activation via independent mechanisms, with each pathway leading to unique spatiotemporal consequences. 8 Whereas G protein-dependent ERK translocates to the nucleus for gene transcription, arrestin-dependent ERK remains within the cytoplasm. Because arrestins preferentially bind to some, but not all, GPCRs in a ligand-dependent manner, we envision that arrestins may play a role in GPCR crosstalk by coordinating MAPK activation in distinct subcellular compartments. Such a regulatory mechanism is essential for modulating MAPK signaling in divergent cellular functions such as cell proliferation and growth, 9 mobility, 10 and apoptosis. 11 We chose cardiac fibroblasts as a model to study GPCR signaling crosstalk. Both ␣ 1 -adrenergic receptor (␣ 1 ARs) and ␤ARs are expressed in cardiac tissue and are activated by catecholamines to modulate maladaptive cardiac remodeling, including cardiac fibroblast proliferation, by activation of distinct pathways. These pathways transduce their proliferative signal via members of the MAPK family, including ERK1/2. Stimulation of the ␣ 1 AR leads to Gq coupling and subsequent PLC and protein kinase (PK)C activation. 12 PKC has been shown to directly activate the Raf-MEK1-ERK axis. The activated ERK translocates to the nucleus to activate gene transcription necessary for cellular differentiation, proliferation, and growth. 13 Meanwhile, stimulation of ␤AR signaling leads to ERK activation in a Gi-dependent manner via G ␤ ␥ subunits. 9 Alternatively, activated ␤ARs associate with arrestins, leading to receptor internalization and arrestinmediated ERK activation from both the ␤ 1 AR 14 and the ␤ 2 AR. 8 The latter G protein-independent mechanism leads to cytosolic ERK retention for phosphorylation of cytosolic targets.
Here we have identified a novel mechanism regulating Gq-coupled receptor-induced MAPK signaling via crosstalk with ␤ 2 AR-recruited arrestin (Arr)3 in mouse cardiac fibroblasts and embryonic fibroblasts (MEFs). This is the first evidence suggesting that arrestin activation by one GPCR is capable of regulating a signaling pathway originating from another GPCR. These studies also provide a novel mechanism explaining the coordination of subcellular mitogenic signaling elicited from different GPCR stimuli.
Methods
Animal care and use was in accordance with institutional guidelines. Neonatal cardiac fibroblasts were isolated from new born mice using a collagenase dispersion procedure with a preplating step, as described previously. 14a Cardiac fibroblasts or MEF cells were then transfected, if indicated, with either arrestin, GRK, Src, or AR constructs using Lipofectamine 2000 according to the instructions of the manufacturer (Invitrogen). For Western blotting, cells were pretreated with the indicated drugs and then stimulated with adrenergic agonists or antagonists for the indicated times. Cell lysates were then subjected to Western blotting with antibodies accordingly. The cell proliferation ELISA was carried out using bromodeoxyuridine (BrdUrd) Labeling and Detection Kit III (Roche) according to the instructions of the manufacturer. Student's t test was performed using Prism software (GraphPad).
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results

Agonist-Dependent Spatiotemporal Activation of ERK on Stimulation of ARs in Cardiac Fibroblasts
Both ␣ 1 ARs and ␤ARs are implicated in promoting ERK activation on stimulation with catecholamines. 15 Using cardiac fibroblasts, we investigated the mechanism leading to the modulation of ERK signaling on potential crosstalk between these GPCRs. We examined agonist-dependent ERK phosphorylation induced by epinephrine (Epi). Because ␣ 1 ARs are the primary ARs responsible for ERK activation in cardiac tissues, we used the ␣ 1 AR-specific agonist phenylephrine (Phe). Both Epi and Phe activated ERK by increasing the phosphorylation of ERK (phospho-ERK). The maximal phospho-ERK levels peaked at 5 minutes after stimulation, with the peak levels induced by Phe significantly lower than that by Epi. Moreover, the Epi-induced phospho-ERK underwent a rapid decrease to baseline, whereas, the Phe-induced phospho-ERK signal was prolonged and returned to baseline levels slowly ( Figure 1A) .
Previous studies have indicated that subcellular ERK distribution may shape the temporal profile of ERK activation. 16 We found that Epi-induced phospho-ERK accumulated in the cytosol and returned to baseline levels rapidly ( Figure 1B) . Interestingly, Phe-induced phospho-ERK translocated to the nucleus and remained elevated throughout stimulation ( Figure 1B) . The subcellular distribution of phospho-ERK was confirmed in fractionation studies. The Epi-induced phospho-ERK was enriched in the cytosolic fraction; however, the Phe-induced phospho-ERK was enhanced in both the cytosolic and nuclear fractions ( Figure  1C ). Thus, concomitant activation of the ␤ and ␣ 1 ARs by Epi induces a distinct spatiotemporal ERK signal than that elicited by activation of the ␣ 1 AR alone by Phe.
ERK Activation Is Induced by a Classic ␣ 1 AR/Gq Pathway in Cardiac Fibroblasts
To investigate the mechanism underlying the modulation of ERK signaling on AR crosstalk, we first examined which AR was responsible for ERK phosphorylation. Stimulation with Epi and Phe induced potent ERK activation (Figure 2A) . Stimulation with the ␤AR agonist isoproterenol (Iso) resulted in minimal ERK activation, whereas, stimulation of the ␣ 2 ARs with clonidine did not activate ERK (Figure 2A ). In addition, pretreatment with the ␣ 1 AR antagonist prazosin, but not the ␤AR antagonist timolol (Tim) or the ␣ 2 AR antagonist yohimbine, significantly blocked Epi-induced ERK activation ( Figure 2B and data not shown). As a control, prazosin and yohimbine, as well as a panel of ␤-blockers including Tim, propranolol, alprenolol, and carvedilol did not alter basal ERK levels (Online Figure I) . Previous studies show that activation of ␤ARs can induce cell-specific ERK activation. 17 Similar to neonatal cardiac fibroblasts, Iso induced minimal ERK phosphorylation in MEFs, and in both neonatal and adult cardiac myocytes. In contrast, stimulation of ␤ARs with Iso induced robust ERK phosphorylation in HEK293 (human embryonic kidney 293) cells (Online Figure II) . Together, these results confirmed that ERK activation resulted primarily from ␣ 1 AR stimulation in cardiac fibroblasts, which was supported by the expression of both ␣ 1A AR and ␣ 1B AR genes (Online Figure III) . Accordingly, stimulation of Gq with
Pasteurella multocida toxin and stimulation of PKC with phorbol myristate acetate (PMA) was sufficient to induce potent ERK activation ( Figure 2 and data not shown). In contrast, direct inhibition of Gi with pertussis toxin had no effect on agonist-induced ERK activation (Online Figure IV) . Pretreatment with the PKA inhibitor H89, which blocks Gs signaling, also had no significant effect on agonist-induced ERK activation (Online Figure IV) . Together, these data confirm that the ␣ 1 ARs are the primary adrenergic subtypes responsible for ERK phosphorylation via Gq activation in cardiac fibroblasts. Classic ␣ 1 AR/Gq coupling activates PLC to produce diacyl glycerol, leading to PKC activation. Pretreatment with the PLC inhibitor U73122 significantly blocked both Epi-and Phe-induced ERK phosphorylation ( Figure 2C U1026 also prevented both Epi and Phe-induced ERK activation ( Figure 2C and 2D). These data confirm that ␣ 1 ARinduced ERK signaling is dependent on activation of PLC and PKC leading to the Raf-MEK pathway. 18 
␤AR Activation Prevents Nuclear Translocation of ␣ 1 AR-Induced phospho-ERK and Cardiac Fibroblast Proliferation
One possible explanation for the differences in the spatiotemporal ERK activation profile between Epi and Phe is that ␤AR activation by Epi may lead to cytosolic retention of ␣ 1 AR-induced phospho-ERK. To test this hypothesis, we blocked the ␤ARs with Tim before Epi stimulation. Inhibition of the ␤ARs with Tim redistributed the Epi-induced phospho-ERK to both the cytosol and the nucleus, resulting in a similar spatial profile to that induced by Phe ( Figure 3A and 3B). As a result, ␤AR blockade significantly prolonged the phospho-ERK signal ( Figure 3C ). Moreover, simultaneous stimulation of ␤ARs with Iso prevented nuclear translocation of Pheinduced phospho-ERK and promoted phospho-ERK signal attenuation (Online Figure V) . Together, our data suggest that activation of ␤ARs can prevent nuclear translocation of phospho-ERK induced by the ␣ 1 AR/Gq signaling pathway.
To understand the physiological consequence of cytosolic ERK sequestration on ␣ 1 AR and ␤AR crosstalk in cardiac fibroblasts, we examined cell proliferation using BrdUrd incorporation on different ligand stimulation. Activation of the ␣ 1 ARs with Phe, but not the ␤ARs with Iso, induced a significant increase in BrdUrd incorporation, which was blocked by the MEK inhibitor U1026. Further, activation of both the ␣ 1 AR and ␤ARs with Epi did not significantly enhance BrdUrd incorporation. However, inhibition of ␤ARs with Tim enabled Epi to stimulate BrdUrd incorporation ( Figure 3D ), presumably because of the redistribution of phospho-ERK to the nucleus for gene transcription ( Figure  3A ). This increase in BrdUrd incorporation was again blocked by U1026. phospho-ERK signal ( Figure 4C ). Stimulation of double knockout (KO) cells, which lack both ␤AR subtypes, with Epi induced phospho-ERK in both the cytosol and nucleus ( Figure 4D and 4E) . We then reintroduced either ␤ 1 AR or ␤ 2 AR into double KO cells with similar expression levels (data not shown). Expression of ␤ 2 AR, but not ␤ 1 AR, recovered the cytosolic retention of phospho-ERK induced by Epi ( Figure 4D and 4E) . Thus, the effect is ␤ 2 AR-specific, and is not attributable to the higher endogenous expression levels of the ␤ 2 AR than the ␤ 1 AR in cardiac fibroblasts. 19 Together, these data suggest that activation of the ␤ 2 AR modulates both the spatial and temporal profile of ␣ 1 ARinduced ERK activation in cardiac fibroblasts.
␤ 2 AR-Dependent Recruitment of Arrestin Is Necessary to Sequester ␣ 1 AR-Induced ERK Signaling
We further examined the molecular mechanism explaining this signaling crosstalk. Previous studies reported that ␣ 1D ARs form a heterodimer with ␤ 2 ARs in HEK293 cells, thus altering ␣ 1D signaling, 20 but this ␣ 1 AR subtype is not expressed in cardiac fibroblasts (Online Figure III) . Moreover, neither ␣ 1A AR nor ␣ 1B AR dimerized with ␤ 2 AR (Online Figure VI) . Alternatively, on phosphorylation of the ␤ 2 ARs via GRKs, arrestins are recruited leading to receptor internalization, 21 and the internalized ␤ 2 AR/arrestin complexes propagate numerous signaling pathways, including ERK pathways. 22 Because of their role in arrestin recruitment, we investigated the role of GRKs in Epi-induced ERK activation. MEF cells were used for selective knockdown individual GRKs. In wild-type (WT) MEF cells, Epi stimulated cytosolic phospho-ERK, similar to cardiac fibroblasts. Selective knockdown of GRK2, but not other GRKs, in MEF cells significantly promoted nuclear accumulation of phospho-ERK induced by Epi ( Figure 5A and Online Figure  VII) . Expression of ␤ARKct, a GRK2 inhibitor that prevents ␤-arrestin recruitment and thus ␤AR internalization, 23 significantly promoted nuclear accumulation of phospho-ERK ( Figure 5B ) and prolonged ERK signaling ( Figure 5C ). These data indicate that the GRK2-mediated phosphorylation of the ␤ 2 AR modulates ERK activation, presumably through ␤-arrestin-mediated scaffolding of ERK. In addition, Src is necessary for arrestin-dependent ␤AR internalization on agonist binding. 24 Inhibition of Src with either overexpression of dominant negative Src (DN-Src) or treatment with Src inhibitor PP2 prolonged ERK activation induced by Epi, but had no effect on Phe-induced ERK (Online Figure VIII and data not shown) . Fractionation studies revealed that DN-Src expression enhanced nuclear phospho-ERK translocation on Epi stimulation (Online Figure VIII) . These data suggest that Src-dependent and arrestinmediated ␤ 2 AR internalization is necessary for cytosolic sequestration of the ␣ 1 AR-induced ERK signal under Epi stimulation.
To identify the arrestin(s) responsible for this crosstalk, MEF cells lacking either Arr2 (Arr2-KO) or Arr3 (Arr3-KO) were used. In comparison to WT MEF cells, Epi promoted phospho-ERK translocation to the nucleus in Arr3-KO, but not Arr2-KO MEF cells ( Figure 6A and 6B) . Thus, Arr3 is primarily responsible for the crosstalk between the ␤ 2 and ␣ 1 ARs. We then examined the association between ERK and the ␤ 2 AR/Arr3 complex on agonist stimulation. Epi induced a significant increase in the association between ERK and the ␤ 2 AR/Arr3 complex, which was attenuated by Tim ( Figure  6C and Online Figure IX) . In contrast, neither Phe nor Iso enhanced the association between ERK and the ␤ 2 AR/Arr3 complex; but costimulation with Iso and Phe promoted formation of the complex ( Figure 6C ). Furthermore, a dominant-negative Arr3 (GFP-V54DArr3 25 ) also formed a complex with the ␤ 2 AR, but was not sufficient to promote the binding of ERK to the ␤ 2 AR/Arr3 complex ( Figure 6C ). We Figure 5 . GRK2, but not GRK3, mediates ␤ 2 AR activation-dependent sequestration and attenuation of ␣ 1 AR-induced ERK signal. A, WT cardiac fibroblasts expressing GRK2, GRK3, or GRK5 short hairpin RNA (shRNA) were stimulated with Epi (10 mol/L) for 5 minutes and fixed for phospho-ERK (ERKp) staining. B, WT cardiac fibroblasts expressing an HA-tagged GRK2 inhibitor (␤ARKct) were stimulated with Epi (10 mol/L) for 5 minutes, and the cells were either fixed for phospho-ERK staining or lysed and separated into nuclear and cytosolic fractions. C, WT cardiac fibroblasts expressing HA-tagged ␤ARKct were stimulated with Epi (10 mol/L) the indicated times. Phospho-ERK was normalized against total ERK T . *PϽ0.05; **PϽ0.01; ***PϽ0.001 by unpaired Student's t test (nϭ3).
then used GFP-V54DArr3 to further perturb the crosstalk between the ␤ 2 and ␣ 1 ARs. Expression of GFP-V54DArr3, but not GFP-Arr3, promoted nuclear translocation of the phospho-ERK induced by Epi, which did not colocalize with GFP-V54DArr3 in the cytosol ( Figure 6D and 6E) . In contrast, expression of neither GFP-Arr3 nor GFP-V54DArr3 affected the Phe-induced nuclear accumulation of phospho-ERK ( Figure 6D and 6E) . In cells expressing GFPV54DArr3, the cytosolic and the nuclear accumulation of Epi-induced phospho-ERK was further confirmed by fractionation studies ( Figure 6F ). Not surprisingly, nuclear translocation also prolonged the Epi-induced phospho-ERK signal ( Figure 6G) . Together, these data show that internalization of the ␤ 2 AR via Arr3 induces the crosstalk between the ␣ 1 -and ␤ 2 ARs, leading to ERK sequestration within the cytosol.
Arrestin Modulation of Cellular ERK Signaling via GPCR Crosstalk Is a General Mechanism
To test whether this arrestin-mediated GPCR crosstalk is a general MAPK regulatory mechanism on concomitant acti- vation of multiple GPCRs, we used MEF cells lacking both Arr2 and Arr3 (Arr2/3-KO) to investigate phospho-ERK distribution induced by different Gq-coupled receptors in the absence and presence of ␤ 2 AR activation. Stimulating both WT MEFs and cardiac fibroblasts with either Phe or PMA induced nuclear accumulation of phospho-ERK. Interestingly, stimulation of WT MEF and cardiac fibroblast cells with 2 other Gq-coupled receptor agonists, (Val5) angiotensin II or thrombin, also induced nuclear phospho-ERK accumulation ( Figure 7A and 7B), likely through Gq-dependent pathways. 26 However, on Iso costimulation, Phe-, (Val5) angiotensin II-, thrombin-, and PMA-induced phospho-ERK was sequestered within the cytoplasm in both WT MEF and cardiac fibroblast cells ( Figure 7A and 7B). As expected, in MEF cells lacking ␤-arrestins, or in cardiac fibroblasts expressing the GFP-V54DArr3 mutant, ERK signaling induced by the different stimuli was able to translocate into the nucleus. However, both arrestin deficiency and GFPV54DArr3 expression blocked the effect of ␤ 2 AR activation under Iso stimulation ( Figure 7A and 7B) . Together, these data suggest that arrestin activation by the ␤ 2 AR can sequester Gq-coupled receptor-induced phospho-ERK within the cytosol in both cardiac fibroblasts and MEF cells.
Discussion
In this study, we have identified a novel mechanism regulating Gq-coupled receptor-induced ERK MAPK signaling via crosstalk with ␤ 2 AR-recruited Arr3 in cardiac fibroblasts and MEFs (Figure 8 ). This is the first evidence suggesting that arrestin activation by one receptor is capable of regulating signaling originating from another GPCR. G proteinindependent regulation of GPCR signaling via arrestins is an emerging mechanism explaining the regulation of a growing list of GPCR-mediated signaling including ␣ 2 AR, 16 angiotensin receptors, 22 ␤ 1 AR, 14 ␤ 2 AR, 8 opioid receptors, 27 and the vasopressin receptors 28 . Recruitment of arrestins to a phosphorylated GPCR regulates not only receptor internalization but also intracellular signaling such as transactivation of receptor tyrosine kinases. 2, 6 Arrestin, in addition, scaffolds ERKs, leading to activation, cytosolic retention, 22, 29 and decreased transcription in the nucleus. 30 In reconstituted systems this provides a linear mechanism, however, this model fails to reflect the convoluted signaling networks in vivo. Endogenous ligands, including neurotransmitters and hormonal peptides, bind to multiple receptors present in a cell, activating numerous signaling cascades. Indeed, accumulative evidence supports signal crosstalk among GPCRs, such as between the ␤ 1 AR and the angiotensin 1 receptor, 5 the ␣ 2 AR and the opioid receptors, 31 as well as the c5a receptor and the UDP receptor. 32 Here, our results suggest that arrestin functions as a master regulator, coordinating subcellular ERK activation under multiple extracellular stimuli to inhibit nuclear translocation and facilitate signal attenuation. Considering the ability of arrestin to scaffold different cytosolic signaling components besides ERK, such as Src, Jun N-terminal kinase, and p38, 26 and the ability of arrestin to selectively bind to some, but not all, GPCRs in an agonistdependent fashion, 33 our data suggest a general mechanism of arrestin-mediated crosstalk among GPCRs with broad implications in physiological responses under neurohormonal regulation in vivo.
In cardiac fibroblasts and MEFs, our data indicate that the ␣ 1 ARs make the primary contribution to ERK activation, supporting the dominant roles of these receptor subtypes in cardiac remodeling. 34 Consistent with previous studies, 35 stimulation of the ␣ 1 ARs with Phe induces the classic Gq-dependent activation of PLC and PKC, leading to ERK activation through Raf-MEK1 kinase cascade. Under this signaling cascade, activated ERK translocates to the nucleus. 35 Interestingly, this scenario is completely reshaped when ␤ 2 ARs are coactivated with the ␣ 1 AR on Epi stimulation. Coactivation of the ␣ 1 and ␤ 2 ARs leads to sequestration of phospho-ERK within the cytosol. Under Epi stimulation, it was possible that two pools of ERK existed; a transient pool activated by the ␤ 2 AR and a prolonged pool activated by the ␣ 1 AR. The first pool becomes dominant simply because ␤ 2 ARs are more prominent in cardiac tissues than ␣ 1 ARs. This explanation is unlikely for several reasons. First, ␣ 1 AR antagonist prazosin blocked Epi-induced ERK phosphorylation. Second, stimulation with isoproterenol (a ␤AR agonist) alone induces minimal ERK activation. Third, blockade of the ␤ 2 AR prolonged ERK activation and only slightly decreased maximal ERK levels ( Figure 3C ). Taken together, these data support that ERK activation by Epi and Phe originates from ␣ 1 AR activation. However, under Epi stimulation, ␤ 2 AR activation changes the spatiotemporal profile of ERK signaling by policing ERK to the ␤ 2 AR/Arr3 complex. Cytosolic retention may allow targeting to nonnuclear ERK substrates involved in different cellular stress processes 36 and receptor desensitization. 37 This unique observation highlights the potential diversified physiological consequences under a given extracellular environment when multiple receptors are activated simultaneously. As expected, this Arr3-mediated crosstalk is dependent on the receptor phosphorylation by GRK. Inhibiting GRK2, but not other GRKs, is sufficient to prevent the ␤ 2 AR-dependent modulation of ␣ 1 AR-induced ERK signaling. In addition to sequestering ERK within proximity of cytosolic ERK targets, our data indicate that interaction with Arr3 may facilitate the attenuation of ERK signaling in the cytosol. 38 However, inhibition of phosphatase 2A or dual-specificity phosphatases failed to prevent ERK dephosphorylation (data not shown); thus, the phosphatases involved remain to be identified.
The distinct spatiotemporal profile of ERK activation induced by Gq-coupled receptors in the presence or absence of ␤ 2 AR (and potentially other GPCRs) activation has broad implications in the maladaptive remodeling of different tissues in vivo. Indeed, in cardiac myocytes, the ␤ 1 AR, but not the ␤ 2 AR, appears to crosstalk with Gq-coupled receptors in modulating ERK activation (unpublished data). Gq-coupled receptor signaling and ERK activation play essential roles in long-term pathophysiological cardiac remodeling. 9, 34 Traditionally, activated ERK MAPK translocates to the nucleus to activate transcription factors including Elk-1 39 and GATA-4, 40 leading to fibroblast proliferation and myocyte hypertrophy. Here, this nuclear translocation of ERK is abrogated by arrestin binding to activated ␤ 2 ARs in cardiac fibroblasts; interestingly it can be restored with the clinically-relevant ␤ blocker Tim. Our data thus provide insights into understanding the tissue remodeling observed in patients under chronic treatment with ␤-blockers in various clinical and physiological conditions. In summary, our findings provide the first evidence for the role of ␤ 2 AR-recruited arrestin in regulating signaling from another GPCR. These findings provide a novel mechanism to significantly advance our understanding of the growing profiles of GPCR regulatory pathways. These data further underscore the critical role of signaling crosstalk in the complex regulation of receptor signaling via subcellular localization of signaling components, which will have significant implications in numerous clinical and physiological conditions. Figure 8 . Model explaining the mechanism behind GPCRmediated arrestin-dependent sequestration of ERK induced by another GPCR. Activation of the ␤ 2 AR leads to arrestin recruitment and subsequent ␤ 2 AR internalization. The ␤ 2 AR-bound arrestin assembles a signaling complex, which recruits Gq-coupled receptor-induced ERK. Arrestin can potentially "prime" phosphatases (PPS) to dephosphorylate ␣ 1 AR-induced ERK. This arrestin-ERK complex sequesters ␣ 1 AR-induced ERK within the cytosol and prevents nuclear translocation.
